<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: neuronal cell death</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Parkinson's disease: Parkin protects from neuronal cell death</title>
   	 <description>Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich identify a novel signal transduction pathway, which activates the parkin gene and prevents stress-induced neuronal cell death.</description>
	  <link>http://medicalxpress.com/news/2013-03-parkinson-disease-parkin-neuronal-cell.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Fri, 01 Mar 2013 11:07:03 EST</pubDate>
	 <guid isPermaLink="false">news281358185</guid>
	 
</item>
<item>
     <title>Neuronal activity induces tau release from healthy neurons</title>
   	 <description>Researchers from King's College London have discovered that neuronal activity can stimulate tau release from healthy neurons in the absence of cell death. The results published by Diane Hanger and her colleagues in EMBO reports show that treatment of neurons with known biological signaling molecules increases the release of tau into the culture medi-um. The release of tau from cortical neurons is therefore a physiological process that can be regulated by neuronal activity.</description>
	  <link>http://medicalxpress.com/news/2013-02-neuronal-tau-healthy-neurons.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Fri, 15 Feb 2013 11:20:03 EST</pubDate>
	 <guid isPermaLink="false">news280148351</guid>
	 
</item>
<item>
     <title>Neurons die in Alzheimer's because of faulty cell cycle control before plaques and tangles appear</title>
   	 <description>The two infamous proteins, amyloid-beta (Aβ) and tau, that characterize advanced Alzheimer's disease (AD), start healthy neurons on the road to cell death long before the appearance of the deadly plaques and tangles by working together to reactivate the supposedly blocked cell cycle in brain cells, according to research presented on Dec. 17 at the American Society for Cell Biology's Annual Meeting in San Francisco.</description>
	  <link>http://medicalxpress.com/news/2012-12-neurons-die-alzheimer-faulty-cell.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 17 Dec 2012 13:00:10 EST</pubDate>
	 <guid isPermaLink="false">news274961394</guid>
	 
</item>
<item>
     <title>Genome-scale study identifies hundreds of potential drug targets for Huntington's disease</title>
   	 <description>Scientists searching for ways to develop treatments for Huntington's disease (HD) just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNA interference (RNAi) technology to identify hundreds of &quot;druggable&quot; molecular targets linked to the toxicity associated with the devastating, ultimately fatal disease. The results from this unprecedented genome-scale screen in a human cell model of HD are published in the November 29, 2012 edition of PLOS Genetics. The work was is a collaboration between Buck Institute faculty members Robert E. Hughes, Ph.D., Sean Mooney, Ph.D., Lisa Ellerby, Ph.D. and Juan Botas, Ph.D. at the Baylor College of Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-11-genome-scale-hundreds-potential-drug-huntington.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 29 Nov 2012 17:32:16 EST</pubDate>
	 <guid isPermaLink="false">news273432726</guid>
	 
</item>
<item>
     <title>Therapy combining exercise and neuroprotective agent shows promise for stroke victims</title>
   	 <description>In a study published in the current issue of Restorative Neurology and Neuroscience scientists report that a therapy combining exercise with the neurovascular protective agent S-nitrosoglutathione (GSNO) improved recovery from stroke in a rat model. GSNO is a compound found naturally in the body and it has no known side effects or toxicity.</description>
	  <link>http://medicalxpress.com/news/2012-08-therapy-combining-neuroprotective-agent-victims.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 15 Aug 2012 12:45:09 EST</pubDate>
	 <guid isPermaLink="false">news264253502</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/therapycombi.jpg" width="90" height="90" />
</item>
<item>
     <title>Stress pathway identified as potential therapeutic target to prevent vision loss</title>
   	 <description>A new study identifies specific cell-stress signaling pathways that link injury of the optic nerve with irreversible vision loss. The research, published by Cell Press in the February 9 issue of the journal Neuron, may lead to new strategies that will help to protect vulnerable neurons in the retina after optic nerve damage and diseases.</description>
	  <link>http://medicalxpress.com/news/2012-02-stress-pathway-potential-therapeutic-vision.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 08 Feb 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news247918616</guid>
	 
</item>
<item>
     <title>Antioxidant has potential in the Alzheimer's fight, researchers find</title>
   	 <description>(Medical Xpress) -- When you cut an apple and leave it out, it turns brown. Squeeze the apple with lemon juice, an antioxidant, and the process slows down.</description>
	  <link>http://medicalxpress.com/news/2011-12-antioxidant-potential-alzheimer.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 14 Dec 2011 05:56:53 EST</pubDate>
	 <guid isPermaLink="false">news243064534</guid>
	 
</item>


</channel>
</rss>
